Kolinpharma SpA
MIL:KIP

Watchlist Manager
Kolinpharma SpA Logo
Kolinpharma SpA
MIL:KIP
Watchlist
Price: 9.9 EUR
Market Cap: 16.2m EUR

Net Margin
Kolinpharma SpA

2.4%
Current
6%
Average
3.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
342.3k
/
Revenue
14.1m

Net Margin Across Competitors

No Stocks Found

Kolinpharma SpA
Glance View

Market Cap
16m EUR
Industry
Consumer products

Kolinpharma SpA engages in the research, development, and marketing of food supplements based on natural raw materials of natural origin. The company is headquartered in Lainate, Milano and currently employs 110 full-time employees. The company went IPO on 2018-03-09. The firm offers a number of products, including almetax, which is a food supplement based on alpha-lipoic acid, L-tryptophan, turmeric, vitamins B5, b6 AND C, Chromium picolinade and Zinc that acts synergistically on the main symptoms of menopause; Almatex easy, which enables the preservation of the general well-being of the body; Dolasix, which is a food supplement that acts synergistically in favor of the normal functionality of cartilages and connective tissues; Ivuxur, which is a food supplement based on cranberry ( dried cranberry extract), D-mannose, bearberry and Zinc that is used in the treatment of unary tract infections; Milesax, which is a food supplement based on magnesium bisglycinate, boswellia serrata and L-tryptophan that acts synergistically on contractures, muscles relaxation and mood during the rehabilitation and recovery phases, and Xinepa, among others.

KIP Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
2.4%
=
Net Income
342.3k
/
Revenue
14.1m
What is the Net Margin of Kolinpharma SpA?

Based on Kolinpharma SpA's most recent financial statements, the company has Net Margin of 2.4%.

Back to Top